{"id":49064,"date":"2023-08-29T16:00:37","date_gmt":"2023-08-29T14:00:37","guid":{"rendered":"https:\/\/www.3dnatives.com\/en\/?p=49064"},"modified":"2023-08-29T12:11:45","modified_gmt":"2023-08-29T10:11:45","slug":"research-begins-on-3d-printed-drugs-for-pediatric-care-290820235","status":"publish","type":"post","link":"https:\/\/www.3dnatives.com\/en\/research-begins-on-3d-printed-drugs-for-pediatric-care-290820235\/","title":{"rendered":"Research Begins On 3D Printed Drugs For Pediatric Care"},"content":{"rendered":"

In 2022, the global pharmaceutical industry was valued at $1.4 trillion, but it has only been in the past few years that more buzz has surfaced about 3D printed medications and how their production could revolutionize<\/a> the way we take our medicine. Indeed, the medical sector is no stranger to additive manufacturing, having made significant advances in theory and practice with bioprinting<\/a>, 3D printed prostheses, and surgical<\/a> guides. However, recently more companies<\/a> and researchers have been making inroads into the application and manufacture of 3D printed drugs that provide unique<\/a> options unavailable to traditional pills.<\/p>\n

Unlike their mass-produced relatives, 3D printed pharmaceuticals create a unique medium where it is possible to create fully personalized treatments with the opportunity to control the exact dosage, combine multiple drugs into a single pill, and even better control the release of the drugs within our bodies. With such advanced customizability, it would be possible to better aid the most vulnerable and critical of patients such as children and the elderly. Children in particular require more attentive planning and modified dosages that will not impact their health or development as they grow at such a rapid pace.<\/p>\n